Patent details

LUC00202 Product Name: Acalabrutinib ou un sel pharmaceutiquement acceptable de celui-ci

Basic Information

Publication number:
LUC00202
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP127335057
Legal Status:
Inactive
Application number:
LUC00202
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/20/1479
Marketing Authorization Type:
Marketing Authorization Date:
06/11/2020
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
12/04/2021
First Marketing Authorization date:
06/11/2020
Grant date:
29/04/2022
Activation date:
Publication date:
13/04/2021
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
06/11/2035
SPC Extension Expiration:
06/11/2035
Rejection date:
Withdrawal date:

Owner

From:
12/04/2021
 
 

Name:
Merck Sharp & Dohme B.V.
Address:
Waarderweg 39, 2031 BN Haarlem, Netherlands (NL)

Agent

Name:
MARKS & CLERK LLP
From:
12/04/2021
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC2
Bulletin edition number:
2022/06
Publication date:
03/05/2022
Description:
Section D : Granted supplementary protection certificates – I2 publication

2

Bulletin Heading:
SPC1
Bulletin edition number:
2021/06
Publication date:
04/05/2021
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

Annual Fees

Annual Fee Due Date:
02/08/2032
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
12/04/2021 Incoming Correspondence (Post) 1
12/04/2021 Summary of the product caracteristics 44
12/04/2021 Marketing authorization 3
13/04/2021 Outgoing Correspondence 1
12/04/2021 MA publication 12
12/04/2021 Application Form 4
12/04/2021 General Document 6
13/04/2021 Publication 1
29/04/2022 Publication 1
29/04/2022 Certificate 1
02/05/2022 Outgoing Correspondence 1
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56